The DCGI has offered seven measures for speeding up the process, from giving fast-track approval for repurposed drug to waiving animal study and offering flexible pathways which earlier would have taken months. It said applications from companies will be given “high priority” and that it will assist the companies in speeding up their research.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2wuB8uz
via IFTTT
Subscribe to:
Post Comments (Atom)
-
How to get mentally prepared during the outbreak of COVID-19? (1) Adjust your attitudes and view COVID-19 from a scientific perspective....
-
The health ministry has asked AIIMS to designate part of the new emergency wing at its trauma facility, Jai Prakash Narayan Apex Trauma Cent...
-
By Reuters via NYT World https://ift.tt/2vrReVu
No comments:
Post a Comment